ZBTB42 and central nervous system cancer: To further understand the distribution of ZBTB42 in glioma with different clinical parameters, we analyzed the glioma patients from the CGGA-325 cohort, CGGA-693 cohort, and the TCGA dataset by the Brainbase website.